Your browser doesn't support javascript.
loading
Charting a path through resistance: histone deacetylase inhibitors for TP53-mutated B-cell acute lymphoblastic leukemia.
Kugler, Eitan.
Affiliation
  • Kugler E; Department of Leukemia, UT MD Anderson Cancer Center, Houston TX, USA Rabin Medical Center and Faculty of Medicine, Aviv University, Aviv. ekugler@mdanderson.org.
Haematologica ; 109(6): 1643-1645, 2024 06 01.
Article in En | MEDLINE | ID: mdl-38356461
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Tumor Suppressor Protein p53 / Drug Resistance, Neoplasm / Histone Deacetylase Inhibitors / Mutation Limits: Humans Language: En Journal: Haematologica Year: 2024 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Tumor Suppressor Protein p53 / Drug Resistance, Neoplasm / Histone Deacetylase Inhibitors / Mutation Limits: Humans Language: En Journal: Haematologica Year: 2024 Type: Article